Stay updated on Nivolumab in Pediatric Hypermutant Cancers Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Pediatric Hypermutant Cancers Clinical Trial page.

Latest updates to the Nivolumab in Pediatric Hypermutant Cancers Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This appears to be a minor version bump with no changes to study content or functionality visible to users.SummaryDifference0.1%

- Check26 days agoChange DetectedRevision: v3.4.3 added and v3.4.2 removed; this reflects a site version update rather than changes to study information.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision: v3.4.2 is now displayed; the page shows the new revision and removes the earlier v3.4.1 notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check61 days agoChange DetectedA site-wide notice about government funding status was added and the page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check68 days agoChange DetectedThe update adds a 'Show glossary' option and a 'No FEAR Act Data' disclosure with a 'Revision: v3.4.0' note. It also includes a minor capitalization change to the 'Last Update Submitted' label.SummaryDifference0.2%

- Check83 days agoChange DetectedThe page revision label was updated to v3.3.4 and the previous v3.3.3 entry was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nivolumab in Pediatric Hypermutant Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Pediatric Hypermutant Cancers Clinical Trial page.